DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 49 · March 2016 DOI: 10.1055/s-006-31169

Original Paper

  • 45
    Merrill, R. M.; Thygerson, S. M.; Palmer, C. A.:

    Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy

  • 51
    Ryu, S.; Huh, I.-S.; Cho, E.-Y.; Cho, Y.; Park, T.; Yoon, S. C.; Joo, Y. H.; Hong, K. S.:

    Association Study of 60 Candidate Genes with Antipsychotic-induced Weight Gain in Schizophrenia Patients

    Supporting Information (PDF)
  • 57
    Gahr, M.; Eller, J.; Connemann, B. J.; Schönfeldt-Lecuona, C.:

    Subjective Reasons for Non-Reporting of Adverse Drug Reactions in a Sample of Physicians in Outpatient Care

    Supporting Information (PDF)
  • 62
    McKibben, C. E.; Reynolds, G. P.; Jenkins, T. A.:

    Concurrent Risperidone Administration Attenuates the Development of Locomotor Sensitization Following Sub-Chronic Phencyclidine in Rats

  • 66
    Soyka, M.; Friede, M.; Schnitker, J.:

    Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences?
    Results from an Indirect Meta-Analysis

  • 76
    Mittag, N.; Meister, S.; Berg, A. M. J.; Walther, U. I.:

    A Case Report of a Carbamazepine Overdose With Focus on Pharmacokinetic Aspects

    • Letter to the Editor

  • 79
    Kellner, M.; Nowack, S.; Wortmann, V.; Yassouridis, A.; Wiedemann, K.:

    Does Pregnenolone Enhance Exposure Therapy in Obsessive-Compulsive Disorder? – A Pilot, Interim Report of a Randomized, Placebo-Controlled, Double-Blind Study